E. Premkumar Reddy

Last updated

E. Premkumar Reddy is a molecular biologist specialising in molecular oncology. He is the Director of Experimental Cancer Therapeutics program and Professor in the Departments of Oncological Sciences and Structural and Chemical Biology at the Mount Sinai School of Medicine.

Contents

Education

Reddy obtained his PhD in molecular biology in 1971 from the Regional Research Laboratory and Osmania University, Hyderabad, India. [1] He completed post-doctoral training in the United States of America at the UCLA School of Medicine and the National Cancer Institute (NCI).[ citation needed ]

Professional career

He joined the National Cancer Institute after his post-graduation, with which he was associated till 1984 as the chief of the molecular genetics section. In 1984, he moved to Hoffman LaRoche Roche Institute of Molecular Biology as a full member and in 1986, he joined the Wistar Institute as their deputy director. In 1992, he was appointed as the Director of the Fels Institute for Cancer Research and Molecular Biology, which is affiliated with Temple University. He moved to the Mount Sinai School of Medicine in 2010. Reddy served as a member of the board of directors of NIEHS from 1990-1995. In 1993, he was awarded the Scientific Achievement Award by the American Cancer Society.[ citation needed ]

He has published over 250 papers. The most notable of his findings are the molecular cloning and sequence determination of a number of viral oncogenes and their cellular homologues. According to data published in 2000 by the Institute for Scientific Information, which compiled the list of most highly cited authors, Reddy was amongst the top 0.5% of the most highly cited authors in the world.[ citation needed ]

Reddy co-founded the international cancer journal Oncogene in 1986, for which he served as an Editor from 1986 to 2009. In 2010, he founded a new cancer journal named Genes & Cancer for which he serves as the Editor-in-Chief.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Cold Spring Harbor Laboratory</span> Private, non-profit research institution in New York, United States

Cold Spring Harbor Laboratory (CSHL) is a private, non-profit institution with research programs focusing on cancer, neuroscience, plant biology, genomics, and quantitative biology. It is located in Laurel Hollow on Long Island, New York.

<span class="mw-page-title-main">Icahn School of Medicine at Mount Sinai</span> American medical school

The Icahn School of Medicine at Mount Sinai, formerly the Mount Sinai School of Medicine, is a private medical school in New York City, New York, United States. The school is the academic teaching arm of the Mount Sinai Health System, which manages eight hospital campuses in the New York metropolitan area, including Mount Sinai Hospital and the New York Eye and Ear Infirmary.

Thomas Eugene Shenk is an American virologist. He is currently Emeritus Professor of Life Sciences in the Department of Molecular Biology at Princeton University.

<span class="mw-page-title-main">Van Andel Institute</span> Non-profit organisation in the USA

Van Andel Institute(VAI) is a 501(c)(3) nonprofit biomedical research and science education organization in Grand Rapids, Michigan. VAI was founded by Jay and Betty Van Andel in 1996.

Richard D. Cummings is an American biochemist who is the S. Daniel Abraham Professor of Surgery at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, Massachusetts. He also the chief of the division of surgical sciences within the department of surgery. He is the director of the Harvard Medical School Center for Glycoscience, director of the National Center for Functional Glycomics, and also founder of the Glycomics Core at BIDMC. As of 2018 Cummings is also the scientific director of the Feihi Nutrition Laboratory at BIDMC. Before moving to BIDMC/HMS, Cummings was the William Patterson Timmie Professor and chair of the department of biochemistry at Emory University School of Medicine in Atlanta, Georgia from 2006 to 2015. At Emory, Cummings was a founder in 2007 of the Emory Glycomics Center.

Steven J. Burakoff is a cancer specialist and the author of both Therapeutic Immunology (2001) and Graft-Vs.-Host Disease: Immunology, Pathophysiology, and Treatment (1990). He served as Director of The Tisch Cancer Institute at Mount Sinai (2007-2017), which was created in 2007 to focus on translational medicine. He is the Lillian and Henry M. Stratton Professor of Cancer Medicine at Mount Sinai Medical Center as well as Dean for Cancer Innovation and Chief, Pediatric Oncology at the Icahn School of Medicine.

<span class="mw-page-title-main">Harvey Lodish</span> American cell biologist, born 1941

Harvey Franklin Lodish is a molecular and cell biologist, professor at the Massachusetts Institute of Technology (MIT), Founding Member of the Whitehead Institute for Biomedical Research, and lead author of the textbook Molecular Cell Biology. Lodish's research focused on cell surface proteins and other important areas at the interface between molecular cell biology and medicine.

Paolo Boffetta is an Italian epidemiologist. He is doing research on cancer and other chronic diseases, where he contributed to the understanding of the role of occupation, environment, alcohol, smoking and nutrition in disease development.

Derek LeRoith is a South African endocrinologist and Professor of Medicine and the current Chief of the Hilda and J. Lester Gabrilove, M.D. Division of Endocrinology, Diabetes and Bone Disease and Director of the Metabolism Institute of the Mount Sinai Medical Center in New York City. He is an international expert in insulin-like growth factor-1 (IGF-1).

<span class="mw-page-title-main">Stuart A. Aaronson</span> Author and cancer biologist

Stuart A. Aaronson is an American author and cancer biologist. He has authored more than 500 publications and holds over 50 patents, and was the Jane B. and Jack R. Aron Professor of Neoplastic Diseases and Chairman of Oncological Sciences at The Mount Sinai Hospital in New York City until March 2013, when he assumed the title of Founding Chair Emeritus of the Department of Oncological Sciences. The current Chairman of Oncological Sciences is Ramon E. Parsons.

<span class="mw-page-title-main">Donald E. Ingber</span> American cell biologist and bioengineer (born 1956)

Donald E. Ingber is an American cell biologist and bioengineer. He is the founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He is also a member of the American Institute for Medical and Biological Engineering, the National Academy of Engineering, the National Academy of Medicine, the National Academy of Inventors, and the American Academy of Arts and Sciences.

<span class="mw-page-title-main">Scott L. Friedman</span>

Scott L. Friedman is an American scientist, professor and physician who works in the field of hepatology. Friedman has conducted pioneering research into the underlying causes of scarring, or fibrosis, associated with chronic liver disease, by characterizing the key fibrogenic cell type, the hepatic stellate cell His laboratory has also discovered a novel tumor suppressor gene, KLF6 that is inactivated in a number of human cancers including primary liver cancer. Friedman is the Fishberg Professor of Medicine, and Chief of the Division of Liver Diseases, Mount Sinai School of Medicine in New York. Friedman has two children, a son, Leor Friedman, and a daughter, Yael Friedman.

<span class="mw-page-title-main">Eric Schadt</span> American scientist

Eric Emil Schadt is an American mathematician and computational biologist. He is founder and former chief executive officer of Sema4, a patient-centered health intelligence company, and dean for precision medicine and Mount Sinai Professor in Predictive Health and Computational Biology at the Icahn School of Medicine at Mount Sinai. He was previously founding director of the Icahn Institute for Genomics and Multiscale Biology and chair of the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai.

<span class="mw-page-title-main">Marius Sudol</span> American cellular biologist (born 1954)

Marius Sudol is an American molecular and cellular biologist. He was born in 1954 in Tarnow, Poland. In 1978, he immigrated to the United States to study at The Rockefeller University in New York City, where he received his Ph.D. in 1983. He is currently an Adjunct Faulty at the Icahn School of Medicine at Mount Sinai in NYC.

<span class="mw-page-title-main">Carlos Cordon-Cardo</span> Spanish-born American physician and scientist

Carlos Cordon-Cardo is a Spanish-born American physician and scientist known for his research in experimental pathology and molecular oncology. He holds the "Irene Heinz Given and John LaPorte Given" Chair in Pathology at Mount Sinai School of Medicine.

<span class="mw-page-title-main">Demetrios Spandidos</span> Greek virologist and cancer researcher (born 1947)

Demetrios A. Spandidos is a Greek virologist and cancer researcher. He is an emeritus professor at the University of Crete where he was professor of virology from 1989 till 2015. He is also the founder of Spandidos Publications and the editor-in-chief of all eight of its journals.

Ed Harlow is an American molecular biologist.

Bruce Alan Sullenger is the Joseph W. and Dorothy W. Beard Professor of Experimental Surgery at the Duke University School of Medicine, the Founding Director of the Duke Translational Research Institute (DTRI) which he led from 2006-2016, and the Associate Director for Translation in the Duke Cancer Institute (DCI).

Jacques Banchereau is an internationally prominent French American immunologist and molecular biologist. As of 2022, he is Chief Scientific Officer at Immunai. He was formerly professor and director of immunological sciences at the Jackson Laboratory for Genomic Medicine and also the former chief science officer, senior vice president, and DTA head of inflammation & virology at Hoffman-La Roche. He is best known for his extensive research on dendritic cells with Nobel Laureate Ralph M. Steinman. He is the fifth most cited immunologist ranked by Times Higher Education's report.

Kung Hsiang-fu or Kong Xiangfu was a Chinese molecular geneticist, molecular oncologist, and virologist. He was elected an academician of the Chinese Academy of Sciences in 1999.

References

  1. "Onconova Therapeutics Inc". Bloomberg.com. 26 June 2017. Retrieved 26 June 2017.